The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 10; no. 1; p. 5156
Main Authors N Zekri, Abdel-Rahman, EL Kassas, Mohamed, Salam, El SayedTarekAbd El, Hassan, Reem Mostafa, Mohanad, Marwa, Gabr, Reham Mohamed, M. Lotfy, Mai, Abdel-zaher, Rania A. Talaat, Bahnassy, Abeer A., Ahmed, Ola S.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 20.03.2020
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations.
AbstractList Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations.
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations.Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations.
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations.
ArticleNumber 5156
Author Hassan, Reem Mostafa
M. Lotfy, Mai
Gabr, Reham Mohamed
EL Kassas, Mohamed
Abdel-zaher, Rania A. Talaat
Bahnassy, Abeer A.
Mohanad, Marwa
N Zekri, Abdel-Rahman
Ahmed, Ola S.
Salam, El SayedTarekAbd El
Author_xml – sequence: 1
  givenname: Abdel-Rahman
  surname: N Zekri
  fullname: N Zekri, Abdel-Rahman
  email: ncizekri@yahoo.com
  organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University
– sequence: 2
  givenname: Mohamed
  surname: EL Kassas
  fullname: EL Kassas, Mohamed
  organization: Endemic Medicine Department, Faculty of Medicine, Helwan University
– sequence: 3
  givenname: El SayedTarekAbd El
  surname: Salam
  fullname: Salam, El SayedTarekAbd El
  organization: Botany and Microbiology Department, Faculty of Science, Cairo University
– sequence: 4
  givenname: Reem Mostafa
  orcidid: 0000-0002-7032-4735
  surname: Hassan
  fullname: Hassan, Reem Mostafa
  organization: Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University
– sequence: 5
  givenname: Marwa
  surname: Mohanad
  fullname: Mohanad, Marwa
  organization: Biochemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology
– sequence: 6
  givenname: Reham Mohamed
  surname: Gabr
  fullname: Gabr, Reham Mohamed
  organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University
– sequence: 7
  givenname: Mai
  surname: M. Lotfy
  fullname: M. Lotfy, Mai
  organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University
– sequence: 8
  givenname: Rania A. Talaat
  surname: Abdel-zaher
  fullname: Abdel-zaher, Rania A. Talaat
  organization: Botany and Microbiology Department, Faculty of Science, Cairo University
– sequence: 9
  givenname: Abeer A.
  surname: Bahnassy
  fullname: Bahnassy, Abeer A.
  organization: Molecular pathology unit, pathology Department, National Cancer Institute, Cairo University
– sequence: 10
  givenname: Ola S.
  surname: Ahmed
  fullname: Ahmed, Ola S.
  organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32198440$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAUtFARLaV_gAOyxIVDA_5OwqESaktBKuJSzpbjvOy6m7WD7RTtnR-Ot9tC6aE-2E9-M6N5evMS7fngAaHXlLynhDcfkqCybSrCSKUYkbRSz9ABI0JWjDO296DeR0cpXZNyJGsFbV-gfc5o2whBDtDvqyXgKaTkuhFwDOUKAz5zdrUK01DRY3wRxoXDUwwZnK9wzbHxPf7m-pXzgE0qLeidzSGmLXUJk8nBmmidDwvwkFz6iA2OcOPg1y3XeHy-2EzZlSLlud-8Qs8HMyY4unsP0Y_P51enX6rL7xdfTz9dVlbUIlfQ1UrVQlo1dMrIWllaG6YILf92qEkLRgBpWtZJM9RG8F6QmvGB284M0g78EJ3sdKe5W0NvwedoRj1FtzZxo4Nx-v-Od0u9CDe6Jg1vCSsC7-4EYvg5Q8p67ZKFcTQewpw04w1VTLVSFujbR9DrMEdfxtuiCOFMMFpQbx46-mvlfkEF0OwANpYlRRi0ddlkF7YG3agp0ds46F0cdImDvo2DVoXKHlHv1Z8k8R0pFbBfQPxn-wnWH-NIx9E
CitedBy_id crossref_primary_10_1016_j_livres_2020_09_003
crossref_primary_10_1002_iub_2458
crossref_primary_10_1016_j_aohep_2023_101137
crossref_primary_10_1016_j_jpba_2022_115215
crossref_primary_10_1080_14737140_2022_2139681
crossref_primary_10_1080_17474124_2021_1900731
crossref_primary_10_3390_cancers15194850
crossref_primary_10_1186_s12876_023_02685_8
crossref_primary_10_3390_cells13020136
crossref_primary_10_3390_ijms24054286
crossref_primary_10_3390_jcm10050977
crossref_primary_10_1186_s13000_021_01150_y
Cites_doi 10.1016/S1499-3872(12)60160-X
10.19082/3492
10.1016/S1470-2045(12)70233-4
10.1016/j.clinbiochem.2014.08.010
10.1111/j.1572-0241.2006.00467.x
10.1016/S0009-8981(01)00644-1
10.1111/j.1572-0241.2004.40410.x
10.1002/ijc.25838
10.18632/oncotarget.14954
10.1053/j.gastro.2011.12.061
10.1136/gut.2010.214916
10.1007/s12016-017-8655-y
10.1016/j.apjtm.2017.03.016
10.1093/jnci/djn134
10.1155/2015/146389
10.1159/000320379
10.1007/s12032-014-0367-z
10.1155/2017/5358615
10.1158/0008-5472.CAN-09-3879
10.1371/journal.pone.0151069
10.1016/j.jhep.2012.04.018
10.1158/1078-0432.CCR-12-3363
10.1371/journal.pone.0155800
ContentType Journal Article
Copyright The Author(s) 2020
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/s41598-020-62051-6
DatabaseName Springerlink
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
ProQuest Biological Science
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID PMC7083902
32198440
10_1038_s41598_020_62051_6
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Science and Technology Development Fund (STDF)
  grantid: 5193; 5193; 5193; 5193; 5193; 5193; 5193
  funderid: https://doi.org/10.13039/501100003009
– fundername: ;
  grantid: 5193; 5193; 5193; 5193; 5193; 5193; 5193
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c474t-eb766745c6fb6a576c17a2601b76cf709ea4e0892b5af7a43d40723f3cbaf5cf3
IEDL.DBID M48
ISSN 2045-2322
IngestDate Thu Aug 21 14:30:45 EDT 2025
Fri Jul 11 16:15:36 EDT 2025
Wed Aug 13 10:55:32 EDT 2025
Thu Jan 02 22:56:54 EST 2025
Thu Apr 24 23:10:33 EDT 2025
Tue Jul 01 03:24:08 EDT 2025
Fri Feb 21 02:36:57 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-eb766745c6fb6a576c17a2601b76cf709ea4e0892b5af7a43d40723f3cbaf5cf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-7032-4735
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-020-62051-6
PMID 32198440
PQID 2380032421
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7083902
proquest_miscellaneous_2381626955
proquest_journals_2380032421
pubmed_primary_32198440
crossref_citationtrail_10_1038_s41598_020_62051_6
crossref_primary_10_1038_s41598_020_62051_6
springer_journals_10_1038_s41598_020_62051_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-03-20
PublicationDateYYYYMMDD 2020-03-20
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-20
  day: 20
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References YanQNovel functional proteins interact with midkine in hepatic cancer cellsHepatobiliary Pancreat. Dis. Int.2012113272714161941:CAS:528:DC%2BC38XhtFWhtL%2FF10.1016/S1499-3872(12)60160-X
BarreirosAPPiscagliaFDietrichCFContrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelinesJ. Hepatol.2012574930210.1016/j.jhep.2012.04.018
ShenQSerum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre studyLancet Oncol.2012138817261:CAS:528:DC%2BC38XhtFajsLnK10.1016/S1470-2045(12)70233-4
ColliAAccuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CMEAm. J. Gastroenterol.20061013513231:CAS:528:DC%2BD28XjtlGhsLs%3D10.1111/j.1572-0241.2006.00467.x
LiuTSerum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinomaOncotarget201781016498506281577055369980
Shaheen, K. Y. A., Abdel-Mageed, A. I., Safwat, E., Albreedy, A. M. The value of serum midkine level in diagnosis of hepatocellular carcinoma. Int. J. Hepatol. 1–5, (2015).
HodeibHELshoraOSelimAMohammed SabryNMohamed EL-ashryHSerum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular CarcinomaElectron. physician2017913492810.19082/3492
ZhuWWEvaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinomaClin. Cancer Res.201319143944541:CAS:528:DC%2BC3sXhtFSrtbfP10.1158/1078-0432.CCR-12-3363
SongPTangWKokudoNSerum biomarkers for early diagnosis of hepatocellular carcinomaTransl. Gastrointest. Cancer20143210351:CAS:528:DC%2BC28Xhtlyiu7vO
MaoYGolgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinomaGut201059121687931:CAS:528:DC%2BC3MXpvFCr10.1136/gut.2010.214916
Ferlay, J. et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France. GLOBOCAN v1.0. Int Agency Res Cancer. Available from: http://globocan.iarc.fr (2012).
MaitraAThuluvathPJGP73 and liver disease: a (Golgi) complex enigmaAm. J. Gastroenterol.20049961096810.1111/j.1572-0241.2004.40410.x
TianLSerological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseasesInt. J. Cancer201112981923311:CAS:528:DC%2BC3MXhtVKlsrrK10.1002/ijc.25838
GeTDiagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinomaMed. Oncol.201532310.1007/s12032-014-0367-z
LlovetJMDesign and endpoints of clinical trials in hepatocellular carcinomaJ. Natl Cancer Inst.20081001069871110.1093/jnci/djn134
ÖzkanHDiagnostic and Prognostic Validity of Golgi Protein 73 in Hepatocellular CarcinomaDigestion2011831–283810.1159/000320379
SatoNWnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapyCancer Res.201070135326361:CAS:528:DC%2BC3cXot1Wlu7c%3D10.1158/0008-5472.CAN-09-3879
QiaoYSerum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infectionClin. Biochem.20144716–17216221:CAS:528:DC%2BC2cXhsV2nsbzF10.1016/j.clinbiochem.2014.08.010
Vongsuvanh, R. et al. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. Avila MA, editor. PLoS One11(5), e0155800 (2016).
QinQFWengJXuGXChenCMJiaCKCombination of serum tumor markers dickkopf-1, DCP and AFP for the diagnosis of primary hepatocellular carcinomaAsian Pac. J. Trop. Med.2017104409131:CAS:528:DC%2BC2sXlvFWksrw%3D10.1016/j.apjtm.2017.03.016
Yao, M. et al. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin. Rev. Allergy. (2018).
JangESDiagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular CarcinomaPlos One2011113e015106910.1371/journal.pone.0151069
Li, B. et al. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma. Biomed. Res. Int. 5358615, (2017).
El-SeragHBEpidemiology of viral hepatitis and hepatocellular carcinomaGastroenterology20121421264127310.1053/j.gastro.2011.12.061
LiDMalloryTSatomuraSAFP-L3: A new generation of tumor marker for hepatocellular carcinomaClin. Chim. Acta20013131–21591:CAS:528:DC%2BD3MXnvFGqtLo%3D10.1016/S0009-8981(01)00644-1
L Tian (62051_CR21) 2011; 129
Y Mao (62051_CR22) 2010; 59
AP Barreiros (62051_CR14) 2012; 57
62051_CR23
A Colli (62051_CR3) 2006; 101
HB El-Serag (62051_CR2) 2012; 142
A Maitra (62051_CR9) 2004; 99
62051_CR16
62051_CR13
62051_CR1
T Liu (62051_CR26) 2017; 8
62051_CR6
T Ge (62051_CR19) 2015; 32
JM Llovet (62051_CR15) 2008; 100
QF Qin (62051_CR7) 2017; 10
P Song (62051_CR4) 2014; 3
WW Zhu (62051_CR17) 2013; 19
ES Jang (62051_CR20) 2011; 11
H Özkan (62051_CR24) 2011; 83
Y Qiao (62051_CR25) 2014; 47
H Hodeib (62051_CR8) 2017; 9
D Li (62051_CR5) 2001; 313
T Liu (62051_CR10) 2017; 8
N Sato (62051_CR11) 2010; 70
Q Yan (62051_CR12) 2012; 11
Q Shen (62051_CR18) 2012; 13
References_xml – reference: SatoNWnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapyCancer Res.201070135326361:CAS:528:DC%2BC3cXot1Wlu7c%3D10.1158/0008-5472.CAN-09-3879
– reference: GeTDiagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinomaMed. Oncol.201532310.1007/s12032-014-0367-z
– reference: QinQFWengJXuGXChenCMJiaCKCombination of serum tumor markers dickkopf-1, DCP and AFP for the diagnosis of primary hepatocellular carcinomaAsian Pac. J. Trop. Med.2017104409131:CAS:528:DC%2BC2sXlvFWksrw%3D10.1016/j.apjtm.2017.03.016
– reference: LiDMalloryTSatomuraSAFP-L3: A new generation of tumor marker for hepatocellular carcinomaClin. Chim. Acta20013131–21591:CAS:528:DC%2BD3MXnvFGqtLo%3D10.1016/S0009-8981(01)00644-1
– reference: SongPTangWKokudoNSerum biomarkers for early diagnosis of hepatocellular carcinomaTransl. Gastrointest. Cancer20143210351:CAS:528:DC%2BC28Xhtlyiu7vO
– reference: Shaheen, K. Y. A., Abdel-Mageed, A. I., Safwat, E., Albreedy, A. M. The value of serum midkine level in diagnosis of hepatocellular carcinoma. Int. J. Hepatol. 1–5, (2015).
– reference: JangESDiagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular CarcinomaPlos One2011113e015106910.1371/journal.pone.0151069
– reference: Li, B. et al. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma. Biomed. Res. Int. 5358615, (2017).
– reference: ColliAAccuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CMEAm. J. Gastroenterol.20061013513231:CAS:528:DC%2BD28XjtlGhsLs%3D10.1111/j.1572-0241.2006.00467.x
– reference: MaoYGolgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinomaGut201059121687931:CAS:528:DC%2BC3MXpvFCr10.1136/gut.2010.214916
– reference: El-SeragHBEpidemiology of viral hepatitis and hepatocellular carcinomaGastroenterology20121421264127310.1053/j.gastro.2011.12.061
– reference: Ferlay, J. et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France. GLOBOCAN v1.0. Int Agency Res Cancer. Available from: http://globocan.iarc.fr (2012).
– reference: LiuTSerum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinomaOncotarget201781016498506281577055369980
– reference: YanQNovel functional proteins interact with midkine in hepatic cancer cellsHepatobiliary Pancreat. Dis. Int.2012113272714161941:CAS:528:DC%2BC38XhtFWhtL%2FF10.1016/S1499-3872(12)60160-X
– reference: ShenQSerum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre studyLancet Oncol.2012138817261:CAS:528:DC%2BC38XhtFajsLnK10.1016/S1470-2045(12)70233-4
– reference: LlovetJMDesign and endpoints of clinical trials in hepatocellular carcinomaJ. Natl Cancer Inst.20081001069871110.1093/jnci/djn134
– reference: ZhuWWEvaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinomaClin. Cancer Res.201319143944541:CAS:528:DC%2BC3sXhtFSrtbfP10.1158/1078-0432.CCR-12-3363
– reference: HodeibHELshoraOSelimAMohammed SabryNMohamed EL-ashryHSerum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular CarcinomaElectron. physician2017913492810.19082/3492
– reference: ÖzkanHDiagnostic and Prognostic Validity of Golgi Protein 73 in Hepatocellular CarcinomaDigestion2011831–283810.1159/000320379
– reference: Vongsuvanh, R. et al. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. Avila MA, editor. PLoS One11(5), e0155800 (2016).
– reference: TianLSerological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseasesInt. J. Cancer201112981923311:CAS:528:DC%2BC3MXhtVKlsrrK10.1002/ijc.25838
– reference: QiaoYSerum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infectionClin. Biochem.20144716–17216221:CAS:528:DC%2BC2cXhsV2nsbzF10.1016/j.clinbiochem.2014.08.010
– reference: BarreirosAPPiscagliaFDietrichCFContrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelinesJ. Hepatol.2012574930210.1016/j.jhep.2012.04.018
– reference: Yao, M. et al. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin. Rev. Allergy. (2018).
– reference: MaitraAThuluvathPJGP73 and liver disease: a (Golgi) complex enigmaAm. J. Gastroenterol.20049961096810.1111/j.1572-0241.2004.40410.x
– volume: 11
  start-page: 272
  issue: 3
  year: 2012
  ident: 62051_CR12
  publication-title: Hepatobiliary Pancreat. Dis. Int.
  doi: 10.1016/S1499-3872(12)60160-X
– volume: 9
  start-page: 3492
  issue: 1
  year: 2017
  ident: 62051_CR8
  publication-title: Electron. physician
  doi: 10.19082/3492
– volume: 13
  start-page: 817
  issue: 8
  year: 2012
  ident: 62051_CR18
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(12)70233-4
– volume: 47
  start-page: 216
  issue: 16–17
  year: 2014
  ident: 62051_CR25
  publication-title: Clin. Biochem.
  doi: 10.1016/j.clinbiochem.2014.08.010
– volume: 101
  start-page: 513
  issue: 3
  year: 2006
  ident: 62051_CR3
  publication-title: Am. J. Gastroenterol.
  doi: 10.1111/j.1572-0241.2006.00467.x
– volume: 313
  start-page: 15
  issue: 1–2
  year: 2001
  ident: 62051_CR5
  publication-title: Clin. Chim. Acta
  doi: 10.1016/S0009-8981(01)00644-1
– volume: 99
  start-page: 1096
  issue: 6
  year: 2004
  ident: 62051_CR9
  publication-title: Am. J. Gastroenterol.
  doi: 10.1111/j.1572-0241.2004.40410.x
– volume: 129
  start-page: 1923
  issue: 8
  year: 2011
  ident: 62051_CR21
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.25838
– volume: 8
  start-page: 16498
  issue: 10
  year: 2017
  ident: 62051_CR26
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14954
– volume: 142
  start-page: 1264
  year: 2012
  ident: 62051_CR2
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.12.061
– volume: 59
  start-page: 1687
  issue: 12
  year: 2010
  ident: 62051_CR22
  publication-title: Gut
  doi: 10.1136/gut.2010.214916
– ident: 62051_CR6
  doi: 10.1007/s12016-017-8655-y
– volume: 10
  start-page: 409
  issue: 4
  year: 2017
  ident: 62051_CR7
  publication-title: Asian Pac. J. Trop. Med.
  doi: 10.1016/j.apjtm.2017.03.016
– volume: 100
  start-page: 698
  issue: 10
  year: 2008
  ident: 62051_CR15
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/djn134
– volume: 8
  start-page: 16498
  issue: 10
  year: 2017
  ident: 62051_CR10
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14954
– ident: 62051_CR16
  doi: 10.1155/2015/146389
– volume: 83
  start-page: 83
  issue: 1–2
  year: 2011
  ident: 62051_CR24
  publication-title: Digestion
  doi: 10.1159/000320379
– volume: 32
  issue: 3
  year: 2015
  ident: 62051_CR19
  publication-title: Med. Oncol.
  doi: 10.1007/s12032-014-0367-z
– ident: 62051_CR1
– ident: 62051_CR23
  doi: 10.1155/2017/5358615
– volume: 70
  start-page: 5326
  issue: 13
  year: 2010
  ident: 62051_CR11
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-3879
– volume: 11
  start-page: e0151069
  issue: 3
  year: 2011
  ident: 62051_CR20
  publication-title: Plos One
  doi: 10.1371/journal.pone.0151069
– volume: 57
  start-page: 930
  issue: 4
  year: 2012
  ident: 62051_CR14
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2012.04.018
– volume: 3
  start-page: 103
  issue: 2
  year: 2014
  ident: 62051_CR4
  publication-title: Transl. Gastrointest. Cancer
– volume: 19
  start-page: 3944
  issue: 14
  year: 2013
  ident: 62051_CR17
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-12-3363
– ident: 62051_CR13
  doi: 10.1371/journal.pone.0155800
SSID ssj0000529419
Score 2.4016888
SecondaryResourceType review_article
Snippet Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate...
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5156
SubjectTerms 631/67/1857
692/53/2421
692/53/2423
82
82/1
Adult
alpha-Fetoproteins - metabolism
Biomarkers
Biomarkers, Tumor - blood
Biomarkers, Tumor - metabolism
Carcinoma, Hepatocellular - blood
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
Cirrhosis
Dkk1 protein
Female
Golgi apparatus
Hepatocellular carcinoma
Humanities and Social Sciences
Humans
Intercellular Signaling Peptides and Proteins - blood
Intercellular Signaling Peptides and Proteins - metabolism
Liver cancer
Liver cirrhosis
Liver Neoplasms - blood
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Male
Membrane Proteins - analysis
Membrane Proteins - blood
Membrane Proteins - metabolism
Middle Aged
Midkine
Midkine - blood
Midkine - metabolism
multidisciplinary
Prognosis
Protein Precursors - blood
ROC Curve
Science
Science (multidisciplinary)
Sensitivity and Specificity
Serum levels
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BERIXxLuBgozEjVqNYydOuCAELRUSnKi0t8hx7Dbqylma7YF7f3hnnGyqpaLX2FbizOd5eOxvAD7Q_RHiseOZaC1XOhe8yY3jyrlCOFmVVRPZPn8VxyfqxyJfTBtuw3SscqMTo6Jue0t75AdoWhCAlMD8vPrDqWoUZVenEhr34QFRlxGq9ULPeyyUxVKimu7KpLI8GNBe0Z0yipkyxCMvtu3RLSfz9lnJfxKm0Q4dPYHHkwPJvowSfwr3XHgGD8eSkn-fwxXKna16QvrSMTo7yHrPvnX2_LxfeS722fd-edqxyM_QBc60ZCa07GdHhbkcMwM2UfKGqvDQ0DO0V2s0eBe2C_0pacZu-MQMG--8xLEmsEOqZoZIY5Gu9gWcHB3-_nrMp0oL3Cqt1tw1uii0ym3hm8JgCGKFNkQ2hs-t12nljHJpWWUoR6-Nki3xqkkvbWN8br18CTuhD24XmBG-wpiwUrbJlMNoBP0Jr2XrjE6tKH0CYvO_azvRkFM1jGUd0-GyrEcZ1SijOsqoLhL4OI9ZjSQcd_be24ixnhbkUN_AJ4H3czMuJcqPmOD6y9hHYHxX5XkCr0apz6-TqNlLpdIE9BYe5g5E073dErqzSNet0cut0iyB_Q1ybj7r_7N4ffcs3sCjjFCcStRze7Czvrh0b9E9Wjfv4hq4BnBzDQk
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVkhcEO-mFGQkbtQijp044baClmoluECl3iLHa7dRV86quz1w7w9nxnmgpYDENfYojmc8j4znG4C3VD9COHY8EwvLlc4Fb3LjuHKuEE5WZdVEtM-vxemZmp_n5zuQjbUw8dJ-hLSManq8HfZ-jYaGisEo2MlQkHhxD_YIqh1le282m3-bT39WKHelRDVUyKSy_APxthW641revSH5W5o0Wp-TR_BwcBvZrF_oY9hx4Qnc7xtJ_ngKt8httupIvpeO0Y1B1nn2qbVXV93Kc3HEPnfLi5ZFVIY2cKYlM2HBvrTUjssxs8YhStlQ7x0ivUQrtUEzd23b0F2QPmzXH5hhfaVLpDWBHVMPM5QvFkFqn8HZyfH3j6d86K_ArdJqw12jiwK30Ba-KQwGHlZoQxBj-Nx6nVbOKJeWVYbc89oouSA0NemlbYzPrZfPYTd0we0DM8JXGAlWyjaZchiDoBfhtVw4o1MrSp-AGPe7tgP4OPXAWNYxCS7LuudRjTyqI4_qIoF3E82qh9745-zDkY31cAzXNfojqLUo653Am2kYDxBlRUxw3U2cIzCqq_I8gRc916fXSdTnpVJpAnpLHqYJBM69PRLaywjSrdG3rdIsgaNRcn4t6-9fcfB_01_Cg4ykOpWo7Q5hd3N9416hk7RpXg-n4id4iQxI
  priority: 102
  providerName: Springer Nature
Title The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study
URI https://link.springer.com/article/10.1038/s41598-020-62051-6
https://www.ncbi.nlm.nih.gov/pubmed/32198440
https://www.proquest.com/docview/2380032421
https://www.proquest.com/docview/2381626955
https://pubmed.ncbi.nlm.nih.gov/PMC7083902
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_tQ6C9THyOjFEZiTcWiBMnTpAQKqVjqrQJAZX6FjmuvUWrktJ2EnvnD-fOSQpjG0-RYlv5uN_57nK53wG8ovoR4rHzQz7VvpAx94tYGV8Yk3ATZWlWOLbP0-R4LEaTeLIBXbuj9gUubw3tqJ_UeDF78_PH1QdU-PdNyXj6dolGiArFKBAKEWR-sgnbaJkkdTQ4ad39hus7zATP2tqZ25fuwP0ItTgV9Dnkb1N1w_-8-RvlP7lUZ6KOHsBu61uyfgOGh7Bhqkdwr-k2efUYfiEk2LwmJZgZRr8VstqyT6W-uKjn1ueH7HM9OyuZo24oK5_JiKlqyk5K6tllmFriEOV1qEEPLT1HU7ZCW7jQZVWf0aZZLt8xxZpyGLdWVWxIjc4QhMwx2T6B8dHw--DYb5sw-FpIsfJNIZNEilgntkgURieaS0U8ZHheWxlkRgkTpFmIIrZSiWhKlGuRjXShbKxt9BS2qroyz4ApbjMMFzOhi1AYDFTQ1bAymholA81T6wHv3neuW4ZyapQxy12mPErzRlw5iit34soTD16v18wbfo7_zj7oxJh3UMvRacGtjVLjHrxcD6OWUepEVaa-dHM4hn5ZHHuw10h9fbkOLh7Ia3hYTyAG7-sjVXnumLwlOsBZEHpw2CHnz23d_RT7d97Cc9gJCctBhLvfAWytFpfmBTpNq6IHm3Iie7Dd74--jfD4cXj65SueHSSDnvsQ0XO68hv6ZBYC
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxJtAASPBiVpNYidOkBBCtGVLH6dW2ltwHLuNukqW7laod34Pv5EZJ9lqqeit19jeJDuf55HxfAPwjupHiMeOx1FluFRJxMtEWy6tTSMr8iwvPdvnQTo6kt_HyXgF_gy1MHSsctCJXlFXraFv5BtoWhCAlMD8PP3JqWsUZVeHFhodLHbtxS8M2WafdjZRvu_jeHvr8OuI910FuJFKzrktVZoqmZjUlalGd9tEShOxFl43ToW51dKGWR7jMzulpaiIQ0w4YUrtEuME_u4tuI2GN6RgT43V4psOZc1klPe1OaHINmZoH6mGjWK0GPHP02X7d8WpvXo2858Erbd72w_gfu-wsi8dwh7Cim0ewZ2uheXFY_iNOGPTlnbWxDI6q8haxzZrc3raTh2P1tm3dnJcM88HUTecKcF0U7H9mhqBWaZnOETJIur6Q0tP0D7O0cCembppj0kT17OPTLOuxsav1Q3bou5piGzm6XGfwNGNyOAprDZtY58D05HLMQbNpSljaTH6Qf_FKVFZrUITZS6AaPi_C9PTnlP3jUnh0-8iKzoZFSijwsuoSAP4sFgz7Ug_rp29Noix6BXArLiEawBvF8O4dSkfoxvbnvs5EcaTeZIE8KyT-uJ2Ai1JJmUYgFrCw2IC0YIvjzT1iacHV-hV52EcwPqAnMvH-v9bvLj-Ld7A3dHh_l6xt3Ow-xLuxYToUKCOXYPV-dm5fYWu2bx87fcDgx83vQH_Al07SnI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcKt6kFDASnKi1SezECRJCwO7SUlhViEq9Bcdrt1FXydLdCvXOr-LXMZPHVktFb73Gdl7z9ni-AXhJ9SOEY8fDYGK4VFHA80hbLq2NAyvSJM1rtM9xvHMgPx9Gh2vwp6uFoWOVnU6sFfWkMrRH3kfTggxICcy-a49F7A9G72Y_OXWQokxr106jYZE9e_4Lw7f5290B0vpVGI6G3z_u8LbDADdSyQW3uYpjJSMTuzzW6HqbQGkC2cLrxik_tVpaP0lDfH-ntBQTwhMTTphcu8g4gfe9AeuKoqIerH8Yjve_LXd4KIcmg7St1PFF0p-jtaSKNorYQpQGHq9aw0su7uWTmv-ka2srOLoDG637yt43_HYX1mx5D242DS3P78Nv5Do2q0jOppbRyUVWOTYozMlJNXM82GafqulRwWp0iKLkTAmmywn7WlBbMMv0HIcodUQ9gGjpMVrLBZrbU1OU1RHp5WL-hmnWVNzUa3XJhtRLDfmc1WC5D-DgWqjwEHplVdrHwHTgUoxIU2nyUFqMhdCbcUpMrFa-CRLnQdD978y0IOjUi2Oa1cl4kWQNjTKkUVbTKIs9eL1cM2sgQK6cvdWRMWvVwTy7YF4PXiyHUZApO6NLW53VcwKMLtMo8uBRQ_Xl4wTalURK3wO1wg_LCQQSvjpSFsc1WLhCHzv1Qw-2O865eK3_f8Xm1V_xHG6h8GVfdsd7T-B2SAztC1S4W9BbnJ7Zp-inLfJnrUAw-HHdMvgXcKxQDQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+possible+role+of+Dickkopf-1%2C+Golgi+protein-+73+and+Midkine+as+predictors+of+hepatocarcinogenesis%3A+a+review+and+an+Egyptian+study&rft.jtitle=Scientific+reports&rft.au=N+Zekri%2C+Abdel-Rahman&rft.au=El+Kassas%2C+Mohamed&rft.au=Salam%2C+El+SayedTarekAbd+El&rft.au=Hassan%2C+Reem+Mostafa&rft.date=2020-03-20&rft.eissn=2045-2322&rft.volume=10&rft.issue=1&rft.spage=5156&rft_id=info:doi/10.1038%2Fs41598-020-62051-6&rft_id=info%3Apmid%2F32198440&rft.externalDocID=32198440
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon